Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy L Jackson

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
JAMA Ophthalmology|July 10, 2020
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical TrialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Ophthalmology|April 18, 2016
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled TrialTimothy L Jackson, Riti Desai, Andrew Simpson, et al.
Acta Ophthalmologica|March 1, 2019
Changes in microchip position after implantation of a subretinal vision prosthesis in humansLaura Kuehlewein, Nicole Troelenberg, Krunoslav Stingl, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 26, 2024
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data AnalysisJonathan Y M Lai, David R Riley, Matthew Anson, et al.
Trials|February 1, 2022
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trialTimothy L Jackson, Catey Bunce, Riti Desai, et al.
The British Journal of Ophthalmology|February 26, 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Retina (Philadelphia, Pa.)|July 14, 2015
EXTENT AND LOCATION OF INTRARETINAL AND SUBRETINAL FLUID AS PROGNOSTIC FACTORS FOR THE OUTCOME OF PATIENTS WITH OPTIC DISK PIT MACULOPATHYDavid H W Steel, Tom H Williamson, D Alistair H Laidlaw, et al.
Lancet (London, England)|June 14, 2024
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trialTimothy L Jackson, Riti Desai, Hatem A Wafa, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 5, 2023
The effect of ethnicity on anatomic success following macular hole surgery: a multicentre cohort studyHeidi Laviers, Evangelia Papavasileiou, Charlotte Bruce, et al.
Trials|April 14, 2025
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trialChan Ning Lee, Riti Desai, Lisa Ramazzotto, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
JAMA Ophthalmology|July 10, 2020
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical TrialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Ophthalmology|April 18, 2016
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled TrialTimothy L Jackson, Riti Desai, Andrew Simpson, et al.
Acta Ophthalmologica|March 1, 2019
Changes in microchip position after implantation of a subretinal vision prosthesis in humansLaura Kuehlewein, Nicole Troelenberg, Krunoslav Stingl, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 26, 2024
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data AnalysisJonathan Y M Lai, David R Riley, Matthew Anson, et al.
Trials|February 1, 2022
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trialTimothy L Jackson, Catey Bunce, Riti Desai, et al.
The British Journal of Ophthalmology|February 26, 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Retina (Philadelphia, Pa.)|July 14, 2015
EXTENT AND LOCATION OF INTRARETINAL AND SUBRETINAL FLUID AS PROGNOSTIC FACTORS FOR THE OUTCOME OF PATIENTS WITH OPTIC DISK PIT MACULOPATHYDavid H W Steel, Tom H Williamson, D Alistair H Laidlaw, et al.
Lancet (London, England)|June 14, 2024
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trialTimothy L Jackson, Riti Desai, Hatem A Wafa, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 5, 2023
The effect of ethnicity on anatomic success following macular hole surgery: a multicentre cohort studyHeidi Laviers, Evangelia Papavasileiou, Charlotte Bruce, et al.
Trials|April 14, 2025
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trialChan Ning Lee, Riti Desai, Lisa Ramazzotto, et al.
Pageof 15